Involvement of cancer biomarker C7orf24 in the growth of human osteosarcoma

Anticancer Research

Volumn 31, Issue 4, 2011, Pages 1297-1305

  Uejima, Daisuke ^a,d   Nishijo, Koichi ^a,b   Kajita, Yoichiro ^a,b   Ishibe, Tatsuya ^a,b   Aoyama, Tomoki ^a   Kageyama, Susumu ^e   Iwaki, Hideaki ^e   Nakamura, Takashi ^b   Hirokazu, H D A ^d   Yoshiki, Tatsuhiro ^e,f   Toguchida, Junya ^a,b,c  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d KANSAI MEDICAL UNIVERSITY   (Japan)

^e SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^f KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

glutamyl cyclotransferase; C7orf24; Osteosarcoma

Indexed keywords

BIOLOGICAL MARKER; C724; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL ADHESION; CELL MOTILITY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN TRANSPORT;

BLOTTING, WESTERN; BONE NEOPLASMS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHILD; FEMALE; GAMMA-GLUTAMYLCYCLOTRANSFERASE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOENZYME TECHNIQUES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOBLASTS; OSTEOSARCOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 79956149599     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Nagarajan R, Clohisy D and Weigel B: New paradigms for therapy for osteosarcoma. Curr Oncol Rep 7: 410-414, 2005.
2. Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P, Alvegard TA, Picci P, Capanna R, Bernini G, Müller C, Tienghi A, Wiebe T, Comandone A, Bohling T, Del Prever AB, Brosjö O, Bacci G and Saeter G; Italian and Scandinavian Sarcoma Groups: Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol 23: 8845-8852, 2005. (Pubitemid 46211531)
3. Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, Harris MB, Healey J, Huvos A, Link M, Montebello J, Nadel H, Nieder M, Sato J, Siegal G, Weiner M, Wells R, Wold L, Womer R and Grier H: Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol 23: 2004-2011, 2005.
4. Goorin AM, Schwartzentruber DJ, Devidas M, Gebhardt MC, Ayala AG, Harris MB, Helman LJ, Grier HE and Link MP: Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Onclogy Group Study POG-8651. J Clin Oncol 21: 1574-1580, 2003. (Pubitemid 46594112)
5. DeLaney TF, Park L, Goldberg SI, Hug EB, Liebsch NJ, Munzenrider JE and Suit HD: Radiotherapy for local control of osteosarcoma. Int J Radiot Oncol Biol Phys 61: 492-498, 2005.
6. Kim SY and Helman LJ: Strategies to explore new approaches in the investigation and treatment of osteosarcoma. Cancer Treat Res 152: 517-528, 2009.
7. Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM and Helman LJ: The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10: 182-186, 2004. (Pubitemid 38524889)
8. Maloney EK, McLaughlin JL, Dagdigian NE, Garrett LM, Connors KM, Zhou XM, Blättler WA, Chittenden T and Singh R: An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation. Cancer Res 63: 5073-5083, 2003. (Pubitemid 37022647)
9. Scotlandi K, Manara MC, Nicoletti G, Lollini PL, Lukas S, Benini S, Croci S, Perdichizzi S, Zambelli D, Serra M, García-Echeverría C, Hofmann F and Picci P: Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors. Cancer Res 65: 3868-3876, 2005. (Pubitemid 40616368)
10. Kim SY, Lee CH, Midura BV, Yeung C, Mendoza A, Hong SH, Ren L, Wong D, Korz W, Merzouk A, Salari H, Zhang H, Hwang ST, Khanna C and Helman LJ: Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clin Exp Metastasis 25: 201-211, 2008.
11. Morioka K, Tanikawa C, Ochi K, Daigo Y, Katagiri T, Kawano H, Kawaguchi H, Myoui A, Yoshikawa H, Naka N, Araki N, Kudawara I, Ieguchi M, Nakamura K, Nakamura Y and Matsuda K: Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma. Cancer Sci 100: 1227-1233, 2009.
12. Song B, Wang Y, Xi Y, Kudo K, Bruheim S, Botchkina GI, Gavin E, Wan Y, Formentini A, Kornmann M, Fodstad O and Ju J: Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 28: 4065-4074, 2009.
13. Gougelet A, Pissaloux D, Besse A, Perez J, Duc A, Dutour A, Blay JY and Alberti L: miRNA profiles in osteosarcoma as a predictive tool for ifosfamide response. Int J Cancer 2010 [Epub ahead of print].
14. Kageyama S, Iwaki H, Inoue H, Isono T, Yuasa T, Nogawa M, Maekawa T, Ueda M, Kajita Y, Ogawa O, Toguchida J and Yoshiki T: A novel tumor-related protein, C7orf24, identified by proteome differential display of bladder urothelial carcinoma. Proteomics Clin Appl 1: 192-199, 2007.
15. Masuda Y, Maeda S, Watanabe A, Sano Y, Aiuchi T, Nakajo S, Itabe H and Nakaya K: A novel 21-kDa cytochrome c-releasing factor is generated upon treatment of human leukemia U937 cells with geranylgeraniol. Biochem Biophys Res Commun 346: 454-460, 2006. (Pubitemid 43902707)
16. Zhang C, Li HR, Fan JB, Wang-Rodriguez J, Downs T, Fu XD and Zhang MQ: Profiling alternatively spliced mRNA isoforms for prostate cancer classification. BMC Bioinformatics 7: 202, 2006.
17. Xu L, Geman D and Winslow RL: Large-scale integration of cancer microarray data identifies a robust common cancer signature. BMC Bioinformatics 8: 275, 2007.
18. Oakley AJ, Yamada T, Liu D, Coggan M, Clark AG and Board PG: The identification and structural characterization of C7orf24 as gamma-glutamyl cyc1 otransferase. An essential enzyme in the gamma-glutamyl cycle. J Biol Chem 283: 22031-22042, 2008.
19. Orlowski M and Meister A: γ-Glutamyl cyclotransferase. Distribution, isozymic forms, and specificity. J Biol Chem 248: 2836-2844, 1973.
20. Meister A and Anderson ME: Glutathione. Annu Rev Biochem 52: 711-760, 1983. (Pubitemid 13030692)
21. Gromov P, Gromova I, Friis E, Timmermans-Wielenga V, Rank F, Simon R, Sauter G and Moreira JM: Proteomic profiling of mammary carcinomas identifies C7orf24, a gamma-glutamyl cyclotransferase, as a potential cancer biomarker. J Proteome Res 9: 3941-3953, 2010.